Mingguang He

Chair Professor of Experimental Ophthalmology, The Hong Kong Polytechnic University, Hong Kong SAR of China

What is an interesting or little-known fact about you?

I really enjoy running long-term studies, such as the Guangzhou Twin Eye Study. We have been running it for more than 15 years! With the Zhongshan Angle Closure Prophylactic trial, we just finished a 14-year visit! 

Why did you decide to pursue ophthalmology/your subspecialty?

Unlike surgery, ophthalmology practice allows us to sit down and operate at the same time. 

Who is someone in ophthalmology/your subspecialty that you feel has been particularly influential over the past 10 years?

Dr Ferrara who developed VEGF antibodies and further translated them into products that have fundamentally changed the way we practice ophthalmology.

What would you like to see change in ophthalmology/your subspecialty over the next 10 years – and why?

We will discover a way to reverse the progression of eye diseases – in particular for the diseases that are traditionally considered irreversible.